Comparison of 11C-Choline PET/CT and Enhanced CT in the Evaluation of Patients With Pulmonary Abnormalities and Locoregional Lymph Node Involvement in Lung Cancer-Reference-Cited by-同舟云学术

Comparison of 11C-Choline PET/CT and Enhanced CT in the Evaluation of Patients With Pulmonary Abnormalities and Locoregional Lymph Node Involvement in Lung Cancer

Published:2012-07 Issue:4 Volume:13 Page:312-320
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Peng Zhongmin,Liu Qingwei,Li Meng,Han Mingyong,Yao Shuzhan,Liu Qi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Non-small cell lung cancer: dual modality PET/CT in preoperative staging;Antoch;Radiology,2003

2. Evaluation of N parameter in the staging of non-small cell lung cancer: role of CT and PET;Spaggiari;Radiol Med,2005

3. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer;Pozo-Rodriguez;J Clin Oncol,2005

4. Role of positron emission tomography computed tomography in carcinoma lung evaluation;Padma;J Cancer Res Ther,2011

5. FDG-PET in staging lung cancer: how does it change the algorithm?;Verhagen;Lung Cancer,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New PET Tracers: Current Knowledge and Perspectives in Lung Cancer;Seminars in Nuclear Medicine;2022-11

2. A nomogram for predicting the risk of lymph node metastasis in T1–2 non-small-cell lung cancer based on PET/CT and clinical characteristics;Translational Lung Cancer Research;2021-01

3. Development of a nomogram for preoperative prediction of lymph node metastasis in non-small cell lung cancer: a SEER-based study;Journal of Thoracic Disease;2020-07

4. Non-FDG PET Tracers for TB Imaging;PET/CT in Tuberculosis;2020

5. LncRNA GMDS‐AS1 inhibits lung adenocarcinoma development by regulating miR‐96‐5p/CYLD signaling;Cancer Medicine;2019-12-20